| Sr.No. |
Technology |
Policy Brief |
Outcome Report |
| 1. |
Intra Ocular Lenses |
|
|
| 2. |
Safety Engineered Syringes |
|
|
| 3. |
Cervical Cancer Screening in India |
|
|
| 4. |
Long Acting Reversible Contraceptives |
|
|
| 5. |
Digital Hemoglobinometer |
|
|
| 6. |
Costing of Health Technology Assessment in India (CHSI) Study |
|
|
| 7. |
Hypothermia detection device |
|
|
| 8. |
Uterine Balloon Tamponade |
|
|
| 9. |
Portable Automated ABR Neonatal Hearing Screening Device |
|
|
| 10. |
TrueNat as a diagnostic tool for tuberculosis under RNTCP in India |
|
|
| 11. |
Pulse Oximeter |
|
|
| 12. |
Automated Resuscitation Device for neonatal |
|
|
| 13. |
RT-PCR kits/ methods for diagnosis of Influenza |
|
|
| 14. |
Screening of Type-2 Diabetes & Hypertension |
|
|
| 15. |
Screening of Hepatitis B and C |
|
|
| 16. |
ECG facility at Primary Health Centres |
|
|
| 17. |
Low-Cost Portable Ventilators |
|
|
| 18. |
Percutaneous Coronary Intervention as compared to Coronary Artery Bypass Grafting in Left Main Coronary Artery Disease |
|
|
| 19. |
Percutaneous Coronary Interventions (PCI) against Optimal Medical Therapy (OMT) for Management of Patients with Single Vessel Coronary Artery Disease(SV-CAD) without Left Main Coronary Artery (LMCA) Involvement. |
|
|
| 20. |
Treatment Modalities for Management of Patients with Multivessel Coronary Artery Disease (MV-CAD). |
|
|
| 21. |
EuroQol-EQVT study to develop Indian EQ-5D |
|
|
| 22. |
Tranexamic Acid for post-partum haemorrhage |
|
|
| 23. |
Haematology Analysers for diagnosis of Dengue |
|
|
| 24. |
TeCHO plus program |
|
|
| 25. |
Population based screening for Chronic Kidney Disease |
|
|
| 26. |
Cholecystectomy |
|
|
| 27. |
Detection of Diabetic Retinopathy |
|
|
| 28. |
Recurrent cost for institutional delivery in different level of Facilities under JSSK |
|
|
| 29. |
Cost Analysis of the Meghalaya Health Benefit Packages |
|
|
| 30. |
Strategies for Oral cancer screening in India |
|
|
| 31. |
Parenteral Iron Therapy for pregnant women |
|
|
| 32. |
Paediatric Cardiac Surgery Program (Hridyam) for Congenital Heart Disease |
|
|
| 33. |
Rapid Diagnostic Kits with Antimicrobial Sensitivity as Point-of-Care Testing in Uncomplicated Urinary Tract Infection |
|
|
| 34. |
Telemedicine-enabled Otoscope for Prevention of Ear Diseases |
|
|
| 35. |
Inj. Gentamicin in neonatal sepsis by ANMs before referral. |
|
|
| 36. |
PET+CT for cancer care in India. |
|
|
| 37. |
Improving Adher3ence through Tuberculosis Medication Regimen using Tuberculosis Monitoring Encouragement Adherence Drive (TMEAD) Intervention in Nasik City of Maharashtra. |
|
|
| 38. |
Rapid Diagnostic Tests (HemoType-Sc, Sickle Scan and Gazelle) for Sickle Cell Disease/ Trait diagnosis |
|
|
| 39. |
Proton Technology Equipment for Cancer treatment |
|
|
| 40. |
Value-Based Pricing for Anti-Cancer Drugs |
|
|
| 41. |
Latent TB Infection Tests Assessing |
|
|
| 42. |
Drug for treatment of multiple myeloma patients |
|
|
| 43. |
First line treatment options of metastatic renal cell carcinoma |
|
|
| 44. |
Drug therapies for the treatment of Chronic Lymphocytic leukaemia(CLL) |
|
|
| 45. |
Treatment for newly diagnosed Chronic Myeloid Leukaemia patiets |
|
|
| 46. |
Bevacizumab plus Chemotherapy for treatment of advanced and metastatic Cervical cancer |
|
|
| 47. |
Second-line treatment for metastatic Breast Cancer in post-menopausal women |
|
|
| 48. |
Temozolamide for treatment of Glioblastoma Multiforme |
|
|
| 49. |
Trastuzumab for management of Breast Cancer in India |
|
|
| 50. |
Price and trade margin regulation of Anti-Cancer medicines |
|
|
| 51. |
National Cancer Database for Costs and Quality of Life (CaDCQoL) |
|
|
| 52. |
Rapid diagnostic test HPOS (Sicklecert) for Sickle cell diagnosis |
|
|
| 53. |
BPaLM/BPaL for Multi-drug resistant, rifampicin resistant, tuberculosis (MDR-RR-TB) treatment regimen under the National Tuberculosis Elimination Programme (NTEP) |
|
|
| 54. |
Family Planning services to prevent unintended pregnancies in HIV women |
|
|
| 55. |
Rubella vaccination among women in Maharashtra |
|
|
| 56. |
Rotational Atherectomy for Undilatable Lesions |
|
|
| 57. |
Evaluation and Management of Phase- 2 Drug-Resistant Epilepsy |
|
|
| 58. |
Neuromodulator for epilepsy/ Deep Brain Stimulation |
|
|
| 59. |
Intermittent Auscultation (IA) techniques for fetal heart rate monitoring among women |
|
|
| 60. |
Therapeutic hypothermia using Phase Changing Material (MiraCradle) in moderate and severe Hypoxic-Ischaemic Encephalopathy (HIE) |
|
|
| 61. |
Deep Brain Stimulation for Parkinson's disease |
|
|
| 62. |
Microchip-based cellulose acetate electrophoresis rapid test (Gazelle) for Sickle cell diagnosis and Beta Thalassemia |
|
|
| 63. |
Thiamine Supplementation among pregnant and postpartum women to prevent infantile beriberi death |
|
|
| 64. |
iBreast for screening for Breast Cancer |
|
|
| 65. |
COPD Prevention and Control Program in Kerala (SWAAS) |
|
|
| 66. |
Pneumococcal Conjugate Vaccine for pneumococcal disease in Indian Adults |
|
|
| 67. |
Durgama Anchalare Malaria Nirakarana (DAMaN) Programme in Odisha |
|
|
| 68. |
SMART Logistic networks with Drones for TB care and management |
|
|
| 69. |
Project SANKALP in the Rewari district of Haryana |
|
|
| 70. |
Portable Handheld X-ray device |
|
|
| 71. |
Anti-Cancer Drugs: Crizotinib for lung cancer, Nivolumab for Metastatic non-small cell lung cancer, Anzalutamide for prostate cancer |
|
|
| 72. |
FFR Vs. Angiography Guided Percutaneous Coronary Interventions (PCIs) In Patients |
|
|
| 73. |
Total Knee Replacement among Older Adult Population (50 years and above) |
|
|
| 74. |
Implementation of smoking cessation strategies at primary health care settings in Tamil Nadu |
|
|
| 75. |
Report on vagal nerve stimulation |
|
|
| 76. |
Report On TNF-Alpha Inhibitors, B-Cell Inhibitors and Jak Inhibitors For The Treatment |
|
|
| 77. |
AI X-Ray screening and interpretation tools for Tuberculosis |
|
|
| 78. |
Complete Profiling of Tuberculosis (TGS) |
|
|
| 79. |
Cost of diagnosis of infertility and its management |
|
|
| 80. |
Hearing aid devices among older adults |
|
|
| 81. |
Cetuximab for the treatment of Head and Neck Cancers |
|
|
| 82. |
First line maintenance therapy in newly diagnosed advanced Ovarian Cancer |
|
|
| 83. |
Portable intracranial bleed detector |
|
|
| 84. |
SGLT2 inhibitors treatment among patients with Heart Failure |
|
|
| 85. |
IPOM (Intraperitoneal On lay Mesh) technique for laparoscopic hernia repair |
|
|
| 86. |
Vedolizumab drug for management of Inflammatory Bowel Disease |
|
|
| 87. |
Point of Care Test Kit for Hemophilia A and Von Willebrand Disease (VWD) |
|
|
| 88. |
Emicizumab prophylaxis versus no prophylaxis among Haemophilia A patients with and without inhibitors |
|
|
| 89. |
Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) and its impact on Financial Risk Protection |
|
|
| 90. |
ICU ventilators with Neutrally adjusted ventilator Assist |
|
|
